NCTN: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma (E2805)
Getting access
No access information recorded yet.
About this database
| Last updated | 2026-08-25 |
|---|
What exists, and how to get in.
No access information recorded yet.
| Last updated | 2026-08-25 |
|---|